Analyst firms · Raymond James · ARDX
Raymond James ARDX price target and rating history
Ardelyx Inc. (ARDX) · Health Care
Raymond James rates Ardelyx Inc. (ARDX) Strong Buy with a $14 price target, as of its latest action on Sep 3, 2025. It has published 3 rating actions on ARDX since December 2023, including 0 upgrades and 1 downgrade.
- Current rating
- Strong Buy
- Price target
- $14
- Median target, all firms
- Too few
- Actions on ARDX
- 3
Raymond James price target on ARDX
Every Raymond James rating on ARDX
- Sep 3, 2025
- May 2, 2025
- Dec 18, 2023
How other firms rate ARDX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Ladenburg Thalmann | Buy | $16 | Jun 16, 2026 |
| Piper Sandler | Overweight | Jan 9, 2026 |
Questions about Raymond James and ARDX
- What is Raymond James's price target for ARDX?
- Raymond James's latest stated price target for Ardelyx Inc. (ARDX) is $14, from its action on Sep 3, 2025.
- What is Raymond James's rating on ARDX?
- Raymond James rates ARDX Strong Buy, a bullish rating, as of Sep 3, 2025.
- When did Raymond James last change its view on ARDX?
- On Sep 3, 2025, Raymond James resumes coverage at Strong Buy, price target $14.
More ARDX rating histories
All Raymond James ratingsARDX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.